Compare EQT Corporation Common Stock (EQT) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EQT Corporation Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? EQT Corporation Common Stock trades at $52.75 (market cap $33.11B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: EQT Corporation Common Stock is far larger — about 2.6× Halozyme Therapeutics Inc. Common Stock's market cap, and EQT Corporation Common Stock pays a 1.25% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EQT Corporation Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| EQT | HALO | |
|---|---|---|
Market Cap | $33.11B | $12.58B |
Volume | 7,642,959 | 2,179,278 |
Sector | Energy | Health |
52-Week High | $67.93 | $115.22 |
52-Week Low | $48.56 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $38.66B | $14.49B |
Dividend Yield | 1.25% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About EQT Corporation Common Stock
EQT produces and transports natural gas, with production and midstream operations in the Appalachian Basin. Its operations are concentrated in Pennsylvania, West Virginia, and Ohio.
Read more on EQT →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
